MAP2K3 Anticorps
(Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))
Choisissez l’un des 195 anticorps MAP2K3 de notre liste de produits basés sur 6 publications et 141 images de validation.
Découvrez des anticorps MAP2K3 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de MAP2K3 dans plusieurs espèces, y compris Human, Mouse, Rat, Dog, Monkey, Cow, Rabbit, Zebrafish (Danio rerio), Horse, Guinea Pig, Chicken, Chimpanzee, Goat, Pig, et prend en charge diverses applications de recherche telles que WB, IHC, IF, ELISA, IF (cc).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants MAP2K3, issus de différents hôtes tels que Rabbit, Mouse. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de MAP2K3 sont MAP2K3, Map2k3, map2k3.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| MAP2K3 anticorps (N-Term) | Humain, Souris, Rat | Lapin Polyclonal |
|
522,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) | Humain, Souris, Rat | Lapin Polyclonal |
|
522,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (Cy3) | Humain, Souris, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (Cy3) | Humain, Souris, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| MAP2K3 anticorps (N-Term) (Cy3) | Humain, Souris, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (Fluoro488) | Humain, Souris, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| MAP2K3 anticorps (N-Term) (Fluoro488) | Humain, Souris, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (Fluoro488) | Humain, Souris, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| MAP2K3 anticorps (AA 132-160) | Humain, Souris | Lapin Polyclonal |
|
631,13 €
Voir le prix
|
|
| MAP2K3 anticorps (N-Term) (Fluoro647) | Humain, Souris, Rat | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (Fluoro647) | Humain, Souris, Rat | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (PE) | Humain, Souris, Rat | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (PE) | Humain, Souris, Rat | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| MAP2K3 anticorps (N-Term) (PE) | Humain, Souris, Rat | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| MAP2K3 anticorps (C-Term) (Fluoro647) | Humain, Souris, Rat | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- Ig Fraction
- Epitope
- AA 132-160
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain, Souris, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- C-Term
Dernières publications pour nos MAP2K3 Anticorps
: "Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway." dans: Medical science monitor : international medical journal of experimental and clinical research, Vol. 24, pp. 768-781, (2018) (PubMed).
: "MAPK kinase 10.2 promotes disease resistance and drought tolerance by activating different MAPKs in rice." dans: The Plant journal : for cell and molecular biology, Vol. 92, Issue 4, pp. 557-570, (2018) (PubMed).
: "MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3." dans: BMC cancer, Vol. 13, pp. 469, (2013) (PubMed).
: "MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival." dans: Molecular cancer therapeutics, Vol. 6, Issue 4, pp. 1212-22, (2007) (PubMed).
: "Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3." dans: Molecular and cellular biology, Vol. 27, Issue 12, pp. 4217-27, (2007) (PubMed).
: "Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase ..." dans: Molecular biology of the cell, Vol. 14, Issue 2, pp. 529-44, (2003) (PubMed).
: "Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38." dans: Oncogene, Vol. 22, Issue 40, pp. 6129-41, (2003) (PubMed).
: "Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence." dans: Molecular and cellular biology, Vol. 22, Issue 10, pp. 3389-403, (2002) (PubMed).
: "MAPK kinase 10.2 promotes disease resistance and drought tolerance by activating different MAPKs in rice." dans: The Plant journal : for cell and molecular biology, Vol. 92, Issue 4, pp. 557-570, (2018) (PubMed).
: "MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3." dans: BMC cancer, Vol. 13, pp. 469, (2013) (PubMed).
: "MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival." dans: Molecular cancer therapeutics, Vol. 6, Issue 4, pp. 1212-22, (2007) (PubMed).
: "Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3." dans: Molecular and cellular biology, Vol. 27, Issue 12, pp. 4217-27, (2007) (PubMed).
: "Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase ..." dans: Molecular biology of the cell, Vol. 14, Issue 2, pp. 529-44, (2003) (PubMed).
: "Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38." dans: Oncogene, Vol. 22, Issue 40, pp. 6129-41, (2003) (PubMed).
: "Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence." dans: Molecular and cellular biology, Vol. 22, Issue 10, pp. 3389-403, (2002) (PubMed).
Pseudonymes pour MAP2K3 Anticorps
mitogen-activated protein kinase kinase 3 (MAP2K3) Anticorpsmitogen-activated protein kinase kinase 3 (Map2k3) Anticorps
mitogen activated protein kinase kinase 3 (Map2k3) Anticorps
MAP kinase activator XMEK3 (map2k3) Anticorps
AW212142 Anticorps
MAPKK3 Anticorps
MEK3 Anticorps
MKK3 Anticorps
Mkk3 Anticorps
mMKK3b Anticorps
PRKMK3 Anticorps
Prkmk3 Anticorps
SAPKK-2 Anticorps
SAPKK2 Anticorps
Avez-vous cherché autre chose?
- MAP2 Anticorps
- MAP1S Anticorps
- MAP1LC3B2 Anticorps
- MAP1LC3A Anticorps
- MAP1D Anticorps
- MAP1B Anticorps
- MAP1A Anticorps
- MAP1 Anticorps
- MAO Anticorps
- MANSC1 Anticorps
- Mannosyl (Alpha-1,3-)-Glycoprotein beta-1,2-N-Acetylglucosaminyltransferase Anticorps
- Mannose-P-Dolichol Utilization Defect 1 Anticorps
- Mannose-6-Phosphate Receptor (Cation Dependent) Anticorps
- Mannose Receptor Anticorps
- Manic Fringe Anticorps
- MANF Anticorps
- MANEA Anticorps
- MANBA Anticorps
- MAN2B2 Anticorps
- MAN2B1 Anticorps
- MAP2K5 Anticorps
- MAP2K6 Anticorps
- MAP2K7 Anticorps
- MAP3K1 Anticorps
- MAP3K10 Anticorps
- MAP3K11 Anticorps
- MAP3K12 Anticorps
- MAP3K14 Anticorps
- MAP3K15 Anticorps
- MAP3K19 Anticorps
- MAP3K2 Anticorps
- MAP3K4 Anticorps
- MAP3K6 Anticorps
- MAP3K7 Anticorps
- MAP3K7CL Anticorps
- MAP3K8 Anticorps
- MAP3K9 Anticorps
- MAP4 Anticorps
- MAP4K1 Anticorps
- MAP4K2 Anticorps
Vous êtes ici:
